CRMD Long Call Strategy
CRMD (CorMedix Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CRMD (CorMedix Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $588.3M, a trailing P/E of 3.63, a beta of 1.46 versus the broader market, a 52-week range of 6.13-17.43, average daily share volume of 1.3M, a public-listing history dating back to 2010, approximately 64 full-time employees. These structural characteristics shape how CRMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.46 indicates CRMD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 3.63 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a long call on CRMD?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current CRMD snapshot
As of May 15, 2026, spot at $7.55, ATM IV 50.60%, IV rank 4.91%, expected move 14.51%. The long call on CRMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on CRMD specifically: CRMD IV at 50.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a CRMD long call, with a market-implied 1-standard-deviation move of approximately 14.51% (roughly $1.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CRMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on CRMD should anchor to the underlying notional of $7.55 per share and to the trader's directional view on CRMD stock.
CRMD long call setup
The CRMD long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CRMD near $7.55, the first option leg uses a $7.55 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CRMD chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CRMD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $7.55 | N/A |
CRMD long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
CRMD long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on CRMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on CRMD
Long calls on CRMD express a bullish thesis with defined risk; traders use them ahead of CRMD catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
CRMD thesis for this long call
The market-implied 1-standard-deviation range for CRMD extends from approximately $6.45 on the downside to $8.65 on the upside. A CRMD long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CRMD IV rank near 4.91% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CRMD at 50.60%. As a Healthcare name, CRMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CRMD-specific events.
CRMD long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CRMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CRMD alongside the broader basket even when CRMD-specific fundamentals are unchanged. Long-premium structures like a long call on CRMD are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CRMD chain quotes before placing a trade.
Frequently asked questions
- What is a long call on CRMD?
- A long call on CRMD is the long call strategy applied to CRMD (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CRMD stock trading near $7.55, the strikes shown on this page are snapped to the nearest listed CRMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CRMD long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CRMD long call priced from the end-of-day chain at a 30-day expiry (ATM IV 50.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CRMD long call?
- The breakeven for the CRMD long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CRMD market-implied 1-standard-deviation expected move is approximately 14.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on CRMD?
- Long calls on CRMD express a bullish thesis with defined risk; traders use them ahead of CRMD catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current CRMD implied volatility affect this long call?
- CRMD ATM IV is at 50.60% with IV rank near 4.91%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.